Abstract

To test the hypothesis that ATP activation of BK channels in GH(3) cells involves cytosolic phospholipase A(2) (cPLA(2)) as a potential protein target for phosphorylation, we first inhibited the activity of cPLA(2) by both pharmacologic and molecular biologic approaches. Both approaches resulted in a decrease rather than an increase in BK channel activity by ATP, suggesting that in the absence of cPLA(2), phosphorylation of other regulatory elements, possibly the BK channel protein itself, results in inactivation rather than activation of the channel. The absence of changes in activity in the presence of the non-substrate ATP analog 5'-adenylyl-beta,gamma-imidodiphosphate verified that ATP hydrolysis was required for channel activation by ATP. Experiments with an activator and inhibitor of protein kinase C (PKC) support the hypothesis that PKC can be involved in the activation of BK channels by ATP; and in the absence of PKC, other kinases appear to phosphorylate additional elements in the regulatory pathway that reduce channel activity. Our data point to cPLA(2)-alpha (but not cPLA(2)-gamma) as one target protein for phosphorylation that is intimately associated with the BK channel protein.

Highlights

  • Long-term modulation of ion channels is beginning to be appreciated

  • Type II BK channels in mammalian brain reconstituted in lipid bilayers are activated by ATP and ATP analogs via an endogenous protein kinase activity intimately associated with the channel

  • BK channels in GH3 cells appear to belong to the class that is activated in the presence of ATP with or without the addition of exogenous protein kinase, whereas BK channels in GH4 cells appear to be inactivated by ATP or protein kinases and activated by protein phosphatases (14, 15)

Read more

Summary

Introduction

Long-term modulation of ion channels is beginning to be appreciated. This concept suggests that changes in ion channel properties are not dependent on continued occupation of a receptor by an agonist, but rather arise via some long-lasting metabolic modification such as protein phosphorylation (1–3). Treatment of Cells with cPLA2 Antisense Oligonucleotides Eliminates the Activation of BK Channels by MgATP—Because aristolochic acid is a pharmacologic inhibitor of cPLA2 and could possibly be producing its effect on the MgATP response via some other mechanism, we examined the effects of MgATP

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.